Furthermore, the KDIGO 2024 guidelines cover combination therapy from the perspective of SGLT2is being first-line therapy, and long-acting GLP-1 RAs being an add-on in adults with CKD and T2D who have not achieved individualised glycaemic targets despite use of metformin and SGLT2is, or who are unable to use those medications [2]
Wharton hopes both oral drugs will be available to consumers by 2026, though that depends how quickly they move through the FDAs approval process
A low-calorie, low-salt diet will also induce weight loss and reductions in blood pressure, said Sattar
And with compounded GLP-1s largely being phased out, many people will need to switch back
Since cobalamin is a co-factor of methionine synthase, vitamin B 12 deficiency manifests in a decreased methylation of Hcy to Met, which leads to elevated Hcy
Stay patient during the initial weeks, track your progress carefully, and communicate openly with your medical team